CRISPR Therapeutics website screenshot

CRISPR Therapeutics

CRISPR Therapeutics (NASDAQ: CRSP) is a clinical-stage biotechnology company founded in 2013 and headquartered in Zug, Switzerland, with US operations in Boston, Massachusetts. Co-founded by CRISPR/Cas9 pioneer Emmanuelle Charpentier, the company develops transformative gene-based medicines for serious human diseases. Its programs span hemoglobinopathies, immuno-oncology, regenerative medicine, and in-vivo editing; its lead therapy CASGEVY (exagamglogene autotemcel), developed with Vertex Pharmaceuticals, is the first approved CRISPR/Cas9 gene-editing treatment for sickle cell disease and transfusion-dependent beta thalassemia. This is a corporate/investor web presence with no public developer program or API surface.

CRISPR Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Gene Editing, and CRISPR.

CRISPR Therapeutics’ developer surface includes support and 4 more developer resources.

14.6/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyLife SciencesBiotechnologyGene EditingCRISPRGenomicsPharmaceuticals

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 14.6/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.9 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/crispr-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Crispr Therapeutics Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

Operate 1

Status, limits, changes, and where to get help

Commercial 2

Pricing, plans, and the legal terms of use

Company 1

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: crispr-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/crispr-therapeutics.png
name: CRISPR Therapeutics
description: 'CRISPR Therapeutics (NASDAQ: CRSP) is a clinical-stage biotechnology company founded in 2013 and headquartered
  in Zug, Switzerland, with US operations in Boston, Massachusetts. Co-founded by CRISPR/Cas9 pioneer Emmanuelle Charpentier,
  the company develops transformative gene-based medicines for serious human diseases. Its programs span hemoglobinopathies,
  immuno-oncology, regenerative medicine, and in-vivo editing; its lead therapy CASGEVY (exagamglogene autotemcel), developed
  with Vertex Pharmaceuticals, is the first approved CRISPR/Cas9 gene-editing treatment for sickle cell disease and transfusion-dependent
  beta thalassemia. This is a corporate/investor web presence with no public developer program or API surface.'
url: https://raw.githubusercontent.com/api-evangelist/crispr-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- nea
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Life Sciences
- Biotechnology
- Gene Editing
- CRISPR
- Genomics
- Pharmaceuticals
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/crispr-therapeutics-domain-security.yml
- type: Website
  url: https://www.crisprtx.com
- type: PrivacyPolicy
  url: https://crisprtx.com/about-us/privacy-policy
- type: TermsOfService
  url: https://crisprtx.com/about-us/terms-and-conditions
- type: Support
  url: https://crisprtx.com/about-us/contact
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence